Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 13Recruiting 5Active not recruiting 3Withdrawn 2Terminated 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 4Breast 3Tumor-Agnostic 2Other hematologic neoplasm 2Gynecologic 2Gastrointestinal 2CNS 2Head & Neck 1Endocrine 1

Conditions

Neoplasms 2

Interventions

Gemcitabine 13pembrolizumab 12Capecitabine 9Irinotecan 8Erlotinib Hydrochloride 8Carboplatin 8Blood Specimen Collection 8Nivolumab 7Docetaxel 7Cisplatin 7Cetuximab 7Paclitaxel 6Everolimus 6130-nm albumin-bound paclitaxel 6vadimezan 5Magnetic Resonance Spectroscopy 5Fluorouracil 5Cyclophosphamide 5trametinib 4Leucovorin 4Lapatinib 4Ipilimumab 4Bevacizumab 4Albumin-Bound Paclitaxel 4temsirolimus 3atezolizumab 3abemaciclib 3Trastuzumab 3Radiotherapy 3Radiation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Interviews as Topic × Tumor-Agnostic × Clear all
NCT03599661 2025-01-09

Developing and Validating Fertilit-e

Wake Forest University Health Sciences

Terminated
21 enrolled 6 charts
Tumor-Agnostic

Neoplasms

NCT02541162 2018-03-14

COUPLE

Fondation Hôpital Saint-Joseph

Phase NA Terminated
60 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡